Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

GUJARAT THEMIS BIOSYN LTD. - 506879 - Results -Financial Results For March 31, 2023.

 The Board of Directors at its meeting held today, considered and approved the following matters: 1. Approved the Audited Financial Results for the Quarter and Year ended 31st March, 2023. A copy of Audited Financial Results for the Quarter and Year ended 31st March, 2023 is enclosed herewith. (Annexure I). 2. Appointed CS Ketan R. Shirwadkar (ACS 37829) or failing him, CS Prakash Nagringrekar (ACS 5941), Designated Partners of HSPN & Associates LLP, Practicing Company Secretary, Mumbai, as the Scrutinizer for conducting E-Voting and Polling at the 42nd Annual General Meeting. 3. Recommended dividend for Financial Year ended 31.03.2023 of Rs.1/- i.e. @ 20% per equity share having face value of Rs.5/- , aggregating to Rs. 1,45,28,702. The payment is subject to the approval of shareholders at the ensuing AGM 4. Considered the appointment of M/s. RAJA DUTTA & CO., Cost Accountant as the Cost Auditors of the Company.
13-05-2023
Bigul

GUJARAT THEMIS BIOSYN LTD. - 506879 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements), 2015.

 Pursuant to Regulation 23(9) of Listing Regulations, please find enclosed disclosure of Related Party Transactions on a Standalone basis for the half year ended 31st March, 2023. Kindly take the same on your records.
13-05-2023
Bigul

GUJARAT THEMIS BIOSYN LTD. - 506879 - Board Meeting Outcome for Outcome Of Board Meeting Under Reg. 30 Of SEBI (LODR) Regulations, 2015

 The Board of Directors at its meeting held today, considered and approved the following matters: 1. Approved the Audited Financial Results for the Quarter and Year ended 31st March, 2023. A copy of Audited Financial Results for the Quarter and Year ended 31st March, 2023 is enclosed herewith. (Annexure I). 2. Appointed CS Ketan R. Shirwadkar (ACS 37829) or failing him, CS Prakash Nagringrekar (ACS 5941), Designated Partners of HSPN & Associates LLP, Practicing Company Secretary, Mumbai, as the Scrutinizer for conducting E-Voting and Polling at the 42nd Annual General Meeting. 3. Recommended dividend for Financial Year ended 31.03.2023 of Rs.1/- i.e. @ 20% per equity share having face value of Rs.5/- , aggregating to Rs. 1,45,28,702. The payment is subject to the approval of shareholders at the ensuing AGM 4. Considered the appointment of M/s. RAJA DUTTA & CO., Cost Accountant as the Cost Auditors of the Company.
13-05-2023
Bigul

Annual report for Gujarat Themis Biosyn Ltd. for FY-2023
13-05-2023
Bigul

GUJARAT THEMIS BIOSYN LTD. - 506879 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited has received below mentioned intimation / request(s) for Loss of Share Certificate(s) / issuance of duplicate share certificate(s) from the following shareholder(s): Sr. No. Name Folio No. Cert. No. Number of Shares Dist. No. From Dist. No. To 1 YUSUF ROSHANALI BHIKHAPURAWALA Y000094 20768 50 2497501 2497550 2 YUSUF ROSHANALI BHIKHAPURAWALA Y000094 20769 50 2497551 2497600 3 YUSUF ROSHANALI BHIKHAPURAWALA Y000094 20770 50 2497601 2497650 4 YUSUF ROSHANALI BHIKHAPURAWALA Y000094 20771 50 2497651 2497700 We shall issue the duplicate Share Certificate(s) only after the necessary formalities are carried out by the Shareholder(s). This may be taken as compliance under the Listing Regulations
08-05-2023
Bigul

GUJARAT THEMIS BIOSYN LTD. - 506879 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 The Company is scheduling Earning Conference Call on Monday, 15th May 2023 at 10:30 AM. Details of meeting attached below. Note: The schedule of the aforesaid meetings is subject to change. The changes may happen due to exigencies on the part of Fund / Broking House / Company. No Unpublished Price Sensitive Information (UPSI) will be discussed in the meetings/calls. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.gtbl.in
08-05-2023
Bigul

GUJARAT THEMIS BIOSYN LTD. - 506879 - Update on board meeting

 GUJARAT THEMIS BIOSYN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations &Disclosure Requirements) Regulations, 2015, we wish to make further intimation in continuation to the intimation made 04th May, 2023 vide acknowledgement No- 5503092, the Board will also consider and approve the proposal to sub-divide/split of the Equity Shares of the Company in such manner as may be determined by the Board of Directors and subject to approval of the Shareholders and such authorities as may be required.
04-05-2023
Bigul

GUJARAT THEMIS BIOSYN LTD. - 506879 - Board Meeting Intimation for Intimation Of Date Of Board Meeting & Closure Of Trading Window

 GUJARAT THEMIS BIOSYN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2023 ,inter alia, to consider and approve Please be informed that a meeting of the Board of Directors of Gujarat Themis Biosyn Limited is scheduled to be held on Saturday, 13.05.2023 inter alia, to transact the following business: 1.To consider the Audited Financial Results for the Quarter/Year ended on 31.03.2023. 2.To consider recommending Dividend if any on the equity shares of the Company for the financial year 2022-23. Further, in continuation of our Letter dated 27.03.202, the Trading Window in respect of dealing in the Company's Securities was closed for all Directors/Designated Employees from the opening of the trading hours on Saturday, 1stApril, 2023, which shall remain closed till the closure of trading hours on Monday, 15th May, 2023 (both days inclusive) i.e. till the completion of 48 hours after conclusion of the Board meeting as per the policy for prohibition of Insider Trading ("the Code") adopted by the Company pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time.
04-05-2023
Bigul

GUJARAT THEMIS BIOSYN LTD. - 506879 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyGUJARAT THEMIS BIOSYN LTD. 2CIN NO.L24230GJ1981PLC004878 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Rahul Soni Designation: Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Bharat Desai Designation: Chief Financial Officer EmailId: [email protected] Date: 27/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
27-04-2023
Bigul

GUJARAT THEMIS BIOSYN LTD. - 506879 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited has received below mentioned intimation / request(s) for Loss of Share Certificate(s) / issuance of duplicate share certificate(s) from the following shareholder(s): We shall issue the duplicate Share Certificate(s) only after the necessary formalities are carried out by the Shareholder(s). This may be taken as compliance under the Listing Regulations.
27-04-2023
Next Page
Close

Let's Open Free Demat Account